Clear Harbor Asset Management LLC boosted its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 8.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 65,123 shares of the conglomerate’s stock after buying an additional 5,200 shares during the quarter. Danaher accounts for approximately 1.0% of Clear Harbor Asset Management LLC’s portfolio, making the stock its 22nd largest holding. Clear Harbor Asset Management LLC’s holdings in Danaher were worth $14,908,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank Pictet & Cie Europe AG grew its position in Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares during the period. Johnson Investment Counsel Inc. grew its position in Danaher by 2.9% during the third quarter. Johnson Investment Counsel Inc. now owns 664,705 shares of the conglomerate’s stock worth $131,784,000 after buying an additional 18,744 shares during the period. Guinness Asset Management LTD grew its position in Danaher by 13.7% during the third quarter. Guinness Asset Management LTD now owns 223,570 shares of the conglomerate’s stock worth $41,597,000 after buying an additional 26,896 shares during the period. AlphaQuest LLC grew its position in Danaher by 896.1% during the third quarter. AlphaQuest LLC now owns 5,598 shares of the conglomerate’s stock worth $1,110,000 after buying an additional 5,036 shares during the period. Finally, Maxi Investments CY Ltd purchased a new stake in shares of Danaher in the third quarter valued at about $3,251,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Performance
Shares of DHR opened at $182.73 on Monday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market capitalization of $129.33 billion, a price-to-earnings ratio of 35.34, a PEG ratio of 2.44 and a beta of 0.81. The company’s 50 day simple moving average is $182.11 and its 200 day simple moving average is $207.45. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.
Analyst Ratings Changes
DHR has been the topic of several recent research reports. Guggenheim reduced their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. TD Cowen reduced their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Jefferies Financial Group reaffirmed a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. Finally, Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a report on Friday, April 17th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $238.24.
Check Out Our Latest Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
